“The existing condition has exposed some structural weaknesses inside the EU’s medicines source chain plus a superior dependence on non-EU countries for active pharmaceutical ingredients,” Kyriakides said. She advisable that provide chain issues be tackled in an EU pharmaceutical method anticipated to get launched by the tip with the 12 month